New PET tracer shows promise for spotting tumors
NCT ID NCT05989997
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times
Summary
This early-phase study tested a new imaging agent called 68Ga-NOTA-SNA002 in 17 adults with solid tumors. The agent was injected into the bloodstream to see how safe it is and how it spreads in the body using PET scans. The goal was to understand its safety and imaging properties, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Zhongshan Hospital Affiliated to Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.